Human serum is a suitable supplement for the osteogenic differentiation of human adipose-derived stem cells seeded on Poly-3-Hydroxibutyrate-Co-3- Hydroxyvalerate scaffolds

Tissue Engineering - Part A

Volumn 19, Issue 1-2, 2013, Pages 277-289

  De Paula, Ana Cláudia Chagas ^a   Zonari, Alessandra Arcoverde Cavalcanti ^a   Martins, Thaís Maria Da Mata ^a   Novikoff, Silviene ^a   Da Silva, Alexandra Rodrigues Pereira ^a   Correlo, Vitor Manuel ^b   Reis, Rui L ^b   Gomes, Dawidson Assis ^a   Goes, Alfredo Miranda ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF MINHO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE DERIVED STEM CELLS; ALKALINE PHOSPHATASE; BONE MARKERS; BONE TISSUE ENGINEERING; CELL COLONIZATION; CLINICAL APPLICATION; COLLAGEN TYPE I; COMPRESSION TESTS; EX VIVO EXPANSION; FETAL BOVINE SERUM; HUMAN SERUM; HYDROXYVALERATE; IMMUNOLOGICAL REACTIONS; IMMUNOPHENOTYPES; IN-VITRO; MECHANICAL PERFORMANCE; MICROCOMPUTED TOMOGRAPHY; OSTEOCALCIN; OSTEOGENIC; OSTEOGENIC CAPACITY; OSTEOGENIC DIFFERENTIATION; OSTEOPONTIN; POROUS STRUCTURES; SEM MICROGRAPHS; THREE-DIMENSIONAL STRUCTURE;

BODY FLUIDS; BONE; BROMINE COMPOUNDS; COLLAGEN; COMPRESSION TESTING; COMPUTERIZED TOMOGRAPHY; GENE EXPRESSION; PHOSPHATASES; SCANNING ELECTRON MICROSCOPY; STEM CELLS;

SCAFFOLDS (BIOLOGY);

BOVINAE;

POLY(3 HYDROXYBUTYRATE) BLOCK POLY(3 HYDROXYBUTYRATE CO 3 HYDROXYVALERATE); POLY(3-HYDROXYBUTYRATE)-BLOCK-POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYVALERATE); POLYESTER; TISSUE SCAFFOLD;

ADIPOCYTE; ARTICLE; BONE DEVELOPMENT; CELL CULTURE; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; EQUIPMENT DESIGN; EQUIPMENT FAILURE; HUMAN; METABOLISM; OSTEOBLAST; PHYSIOLOGY; SERUM;

ADIPOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; HUMANS; OSTEOBLASTS; OSTEOGENESIS; POLYESTERS; SERUM; TISSUE SCAFFOLDS;

EID: 84871303176     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2012.0189     Document Type: Article

References (49)

1. Dimitriou, R., Jones, E., McGonagle, D., and Giannoudis, P.V. Bone regeneration: Current concepts and future directions. BMC Med 9, 66, 2011.
2. Giannoudis, P.V., Dinopoulos, H., and Tsiridis, E. Bone substitutes: An update. Injury 3, S20, 2005.
3. St. John, T.A., Vaccaro, A.R., Sah, A.P., Schaefer, M., Berta, S.C., Albert, T., and Hilibrand, A. Physical and monetary costs associated with autogenous bone graft harvesting. Am J Orthop 32, 18, 2003.
4. Langer, R., and Vacanti, J.P. Tissue engineering. Science 260, 920, 1993.
5. Salgado, A.J., Coutinho, O.P., and Reis, R.L. Bone tissue engineering: State of the art and future trends. Macromol Biosci 4, 743, 2008.
6. Kose, G.T., Kenar, H., Hasirci, N., and Hasi rci, V. Macroporous poly(3-hydroxybutyrate-co-3-hydroxyvalerate) matrices for bone tissue engineering. Biomaterials 24, 1949, 2003.
7. Ko se, G.T., Korkusuz, F., Korkusuz, P., Purali, N., Ozkul, A., and Hasirci, V. Bone generation on PHBV matrices: An in vitro study. Biomaterials 24, 4999, 2003.
8. Kumarasuriyar, A., Jackson, R.A., Grøndahl L., Trau, M., Nurcombe, V., and Cool, S.M. Poly(b-hydroxybutyrate-co-bhydroxyvalerate) supports in vitro osteogenesis. Tissue Eng 11, 1281, 2005.
9. Halvorsen, Y.C., Franklin, D., Bond, A.L., Hitt, D.C., Auchter, C., Boskey, A.L., Paschalis, E.P., Wilkison, W.O., and Gimble, J.M. Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells. Tissue Eng 7, 729, 2001.
10. Zuk, P.A., Zhu, M., Mizuno, H., Huang, J., Futrell, J.W., Katz, A.J., Benhaim, P., Lorenz, H.P., and Hedrick, M.H. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 7, 211, 2001.
11. Mizuno, H. Adipose-derived stem cells for tissue repair and regeneration: Ten years of research and literature review. J Nihon Med Sch 76, 56, 2009.
12. Lindroos, B., Suuronen, R., and Miettinen, S. The potential of adipose stem cells in regenerative medicine. Stem Cell Rev 7, 269, 2011.
13. Kocaoemer, A., Kern, S., Klu ter, H., and Bieback, K. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 25, 1270, 2007.
14. Lindroos, B., Aho, K., Kuokkanen, H., Ra ty, S., Huhtala, H., Lemponen, R., Yli-Harja, O., Suuronen, R., and Miettinen, S. Differential gene expression in adipose stem cells cultured in allogeneic human serum versus fetal bovine serum. Tissue Eng Part A 16, 2281, 2010.
15. Mitchell, J.B., Mcintosh, K., Zvonic, S., Garrett, S., Floyd, Z.E., Kloster, A., Halvorsen, Y., Storms, R.W., Goh, B., Kilroy, G., Wu, X., and Gimble, J.M. Immunophenotype of human adipose-derived cells: Temporal changes in stromalassociated and stem cell-associated markers. Stem Cells 24, 376, 2006.
16. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65, 55, 1983.
17. Rebelatto, C.K., Aguiar, A.M., Moreta o, M.P., Senegaglia, A.C., Hansen, P., Barchiki, F., Oliveira, J., Martins, J., Kuligovski, C., Mansur, F., Christofis, A., Amaral, V.F., Brofman, P.S., Goldenberg, S., Nakao, L.S., and Correa, A. dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Exp Biol Med 233, 901, 2008.
18. Guillot, P.V., Bari, C., Dell'Accio, F., Kurata, H., Polak, J., and Fish, N.M. Comparative osteogenic transcription profiling of various fetal and adult mesenchymal stem cell sources. Differentiation 76, 946, 2008.
19. Peister, A., Woodruff, M.A., Prince, J.J., Gray, D.P., Hutmacher, D.W., and Guldberg, R.E. Cell sourcing for bone tissue engineering: Amniotic fluid stem cells have a delayed, robust differentiation compared to mesenchymal stem cells. Stem Cell Res 7, 17, 2011.
20. Seong, J.M., Kim, B., Park, J., Kwon, I.K., Mantalaris, A. and Hwang, Y., Stem cells in bone tissue engineering. Biomed Mater 5, 062001, 2010.
21. Halme, D.G., and Kessler, D.A. FDA regulation of stem-cellbased therapies. N Engl J Med 355, 1730, 2006.
22. Mannello, F., and Tonti, G.A. Concise review: No breakthroughs for human mesenchymal and embryonic stem cell culture: Conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned medium, or ad hoc formula? all that glitters is not gold! Stem Cells 25, 1603, 2007.
23. Spees, J.L., Gregory, C.A., Singh, H., Tucker, H.A., Peister, A., Lynch, P.J., Hsu, S., Smith, J., and Prockopy, D.J. Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther 9, 447, 2004.
24. Martin, M.J., Muotri, A., Gage, F., and Varki, A. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med 11, 228, 2005.
25. Heiskanen, A., Satomaa, T., Tiitinen, S., Laitinen, A., Mannelin, S., Impola, U., Mikkola, M., Olsson, C., Miller-Podraza, H., Blomqvist, M., Olonen, A., Salo, H., Lehenkari, P., Tuuri, T., Otonkoski, T., Natunen, J., Saarinen, J., and Laine, J. N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible. Stem Cells 25, 197, 2007.
26. Selvaggi, T.A., Walker, R.E., and Fleisher, T.A. Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood 89, 776, 1997.
27. Aldahmash, A., Haack-Sørensen, M., Al-Nbaheen, M., Harkness, L., Abdallah, B.M., and Kassem, M. Human serum is as efficient as fetal bovine serum in supporting proliferation and differentiation of human multipotent stromal (mesenchymal) stem cells in vitro and in vivo. Stem Cell Rev 7, 860, 2011.
28. Goedecke, A., Wobus, M., Krech, M., Mu nch, N., Richter, K., Ho lig, K., and Bornhauser, M. Differential effect of plateletrich plasma and fetal calf serum on bone marrow-derived human mesenchymal stromal cells expanded in vitro. J Tissue Eng Regen Med 5, 648, 2011.
29. Horn, P., Bokermann, G., Cholewa, D., Bork, S., Walenda, T., Koch, C., Drescher, W., Hutschenreuther, G., Zenke, M., Ho, A.D., and Wagner. W. Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells. Cytotherapy 12, 888, 2010.
30. van de Valk, J., Brunner, D., De Smet, K., Fex Svenningsen,A° ., Honegger, P., Knudsen, L.E., Lindl, T., Noraberg, J., Price, A., Scarino, M.L., and Gstraunthaler, G. Optimization of chemically defined cell culture media-replacing fetal bovine serum in mammalian in vitro methods. Toxicol In Vitro 24, 1053, 2010.
31. Cordonnier, T., Langonné, A., Sohier, J., Layrolle, P., Rosset, P., Sensébé, L., and Deschaseaux, F. Consistent osteoblastic differentiation of human mesenchymal stem cells with bone morphogenetic protein 4 and low serum. Tissue Eng Part C Methods 17, 249, 2011.
32. Mimura, S., Kimura, N., Hirata,M., Tateyama, D., Hayashida, M., Umezawa, A., Kohara, A., Nikawa, H., Okamoto, T., and Furue, M.K. Growth factor-defined culture médium for human mesenchymal stem cells. Int J Dev Biol 55, 181, 2011.
33. Tarle, S.A., Shi, S., and Kaigler, D. Development of a serumfree system to expand dental-derived stem cells: PDLSCs and SHEDs. J Cell Physiol 226, 66, 2011.
34. Chieregato, K., Castegnaro, S., Madeo, D., Astori, G., Pegoraro, M., and Rodeghiero, F. Epidermal growth factor, basic fibroblast growth factor and platelet-derived growth factor-bb can substitute for fetal bovine serum and compete with human platelet-rich plasma in the ex vivo expansion of mesenchymal stromal cells derived from adipose tissue. Cytotherapy 13, 933, 2011.
35. Solmesky, L., Lefler, S., Jacob-Hirsch, J., Bulvik, S., Rechavi, G., and Weil, M. Serum free cultured bone marrow mesenchymal stem cells as a platform to characterize the effects of specific molecules. PLoS One 5, pii:e12689, 2010.
36. Karbanová, J., Soukup, T., Suchánek, J., and Mokrý, J. Osteogenic differentiation of human dental pulp-derived stem cells under various ex-vivo culture conditions. Acta Medica 53, 79, 2010.
37. Scha fer, R., Schnaidt, M., Klaffschenkel, R.A., Siegel, G., Schu le, M., Radlein, M.A., Hermanutz-Klein, U., Ayturan, M., Buadze, M., Gassner, C., Danielyan, L., Kluba, T., Northoff, H., and Flegel, W.A. Expression of blood group genes by mesenchymal stem cells. Br J Haematol 153, 520, 2011.
38. Bieback, K., Hecker, A., Kocaomer, A., Lannert, H., Schallmoser, K., Strunk, D., and Klu ter, H. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 27, 2331, 2009.
39. Shahdadfar, A., FrØndsal, K., Haug, T., Reinholt, F.P., and Brinchmann, J.E. In vitro expansion of human mesenchymal stem cells: Choice of serum is determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells 23, 1357, 2005
40. Bernardo, M.E., Avanzini, M.A., Perotti, C., Cometa A.M., Moretta, A., Lenta, E., Del Fante, C., Novara, F., De Silvestri, A., Amendola, G., Zuffardi, O., Maccario, R., and Locatelli, F. Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: Further insights in the search for a fetal calf serum substitute. J Cell Physiol 211, 121, 2007.
41. Bieback, K., Ha, V.A., Hecker, A., Grassl M., Kinzebach, S., Solz, H., Sticht, C., Klu ter, H., and Bugert, P. Altered gene expression in human adipose stem cells cultured with fetal bovine serum compared to human supplements. Tissue Eng Part A 16, 3467, 2010.
42. Mathieu, L.M., Mueller, T.L., Bourban, P., Pioletti, D.P., Mu ller, R., and Manson, J.E. Architecture and properties of anisotropic polymer composite scaffolds for bone tissue engineering. Biomaterials 27, 905, 2006.
43. Mountford, J.C. Human embryonic stem cells: Origins, characteristics and potential for regenerative therapy. Transfus Med 18, 1, 2008.
44. Riekstina, U., Cakstina, I., Parfejevs, V., Hoogduijn, M., Jankovskis, G., Muiznieks, I., Muceniece, R., and Ancans, J. Embryonic stem cell marker expression pattern in human mesenchymal stem cells derived from bone marrow, adipose tissue, heart and dermis. Stem Cell Rev 5, 378, 2009.
45. Jaiswal, N., Haynesworth, S.E., Caplan, A.I., and Bruder, S.P. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64, 295, 1997.
46. Aubin, J.E. Regulation of osteoblast formation and function. Rev Endocr Metab Disord 2, 81, 2001.
47. Lian, J.B., and Stein, G.S. Concepts of osteoblast growth and differentiation: Basis for modulation of bone cell development and tissue formation. Crit Rev Oral Biol Med 3, 269, 1992.
48. Sodek, J., Ganss, B., and McKee, M.D. Osteopontin. Crit Rev Oral Biol Med 11, 279, 2000.
49. Lian, J.B., and Stein, G.S. Runx2/Cbfa1: A multifunctional regulator of bone formation. Curr Pharm Des 9, 2677, 2003.